Press release
Theranostics Market worth $4.3 billion by 2028

Advanced accelerator applications hold a leading position in theranostics market. The company plans to collaborate with research and academic universities to promote the utilization of Pluvicto and Lutathera. The company also focuses on establishing new p
Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 15.5% from 2023 to 2028 according to a new report by MarketsandMarkets Trademark . The major factors driving the growth of this market include rising number of cancer cases and increasing use of radiophamrceuticals for neurological applications. Therastostics find growth opportunities in emerging countries due to rising incidence of targeted diseases and increasing number of hospitals.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=111696976 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=111696976&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Radiopharmaceuticals segment to register significant growth rate over the forecast period of 2023-2028.
Based on the product, the global theranostics market is segmented into diagnostic imaging, radiopharmaceuticals, IVD/Biomarker screening, and software and services. The radiopharmaceuticals segment is anticipated to register the highest growth rate over the forecast period and also accounted for the highest share of the theranostics market in 2022.
Prostate cancer application segment accounted for the largest share of the theransotics market, by application in 2022.
Based on application, the theranostics market is segmented into prostate cancer, bone metastasis, other cancer, and other applications. The prostate cancer segment accounted for the largest share of the market in 2022 and is also expected to grow at the highest CAGR during the forecast period.
Factors such as the increasing awareness on the benefits of radiopharmaceuticals and rising adoption of theranostics treatment in end user facilities drive the growth of the market.
The hospitals and cancer care segment accounted for the largest share of the theranositcs market, by end user, in 2022
Based on end user, the global theranositcs market is segmented into hospitals and cancer centers, theranostics centers, and research and academic centers. The hospitals and cancer care centers segment accounted for the largest share of the market in 2022. Consistent rise in the number of hospitals and rising old-age population are driving the growth of this segment.
The Asia Pacific market to register the highest growth in the market during the forecast period
The Asia Pacific theranositcs market is anticipated to register the highest growth from 2023 to 2028. The key players of theranostics market are focusing on expanding their footprint in the APAC region. This region is witnessing a significant rise in the adoption of the treatment by different end user facilities in the region. Improvements in healthcare systems and rising healthcare expenditure are offering significant growth opportunities for the key players.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=111696976 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=111696976&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
A breakdown of the primary participants referred to for this report is provided below:
* By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
* By Designation: Director-level-14%, C-level-10%, and Others-76%
* By Region: North America-40%, Europe-32%, Asia Pacific-20%, Rest of the World- 8%
Key Market Players of Theranostics Industry:
As of 2022, prominent players in the theranostics market are Advanced Accelerator Applications (France), Bayer AG (Germany), and GE Healthcare (US) among others.
Advanced Accelerator Applications (France):
Advanced accelerator applications hold a leading position in theranostics market. The company plans to collaborate with research and academic universities to promote the utilization of Pluvicto and Lutathera. The company also focuses on establishing new production sites to increase the sales of its products. Currently, it has a total of 29 sites in 12 countries, including 19 production facilities in 8 countries (in Europe and the US) that are involved in the manufacturing of radioligand therapies and precision imaging radioligands. The geographic presence of the company and its strong distribution channel contribute to a significant percentage of the revenue reported by the company.
Bayer AG (Germany)
Bayer entered the nuclear medicine market in May 2013 with the launch of its blockbuster product Xofigo in the US. It markets diagnostic imaging equipment, together with the necessary contrast agents and prescription products-especially for cardiology and women's healthcare-and specialty therapeutics in the areas of oncology, hematology, and ophthalmology. It operates in more than 100 countries worldwide across North America, Europe, the Asia Pacific, the Middle East & Africa, and Latin America through its subsidiaries and affiliates to help the company and its subsidiaries capture a larger market share. The increasing number of treatments and diagnostic tests performed resulted in a significant increase in volumes.
GE Healthcare (US):
GE Healthcare is one of the leading players in the theranostics market due to its broad product offerings GE Healthcare manufactures products with medical diagnostic technologies, digital solutions, and pharmaceutical diagnostic products for the healthcare sector. The adoption of new technology standards and investments in R&D have made GE Healthcare one of the leading firms in the theranostics market. Collaborations with other companies have also helped the firm establish its presence. The company's comprehensive product portfolio and strong geographical presence with an established distribution channel have helped it gain a competitive edge in the market. It consistently focuses on R&D to deliver novel products.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=111696976 [https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=111696976&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=theranostics-market-worth-43-billion-by-2028]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Theranostics Market worth $4.3 billion by 2028 here
News-ID: 3867781 • Views: …
More Releases from ABNewswire

Cell and Gene Therapy in Parkinson's Disease Market to Experience Notable Growth …
The Key Cell and Gene Therapy in Parkinson's Disease Companies in the market include - Prevail Therapeutics (Eli Lilly), MeiraGTx, Hope Biosciences, and others.
DelveInsight's "Cell and Gene Therapy in Parkinson's Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Cell and Gene Therapy in Parkinson's Disease, historical and forecasted epidemiology as well as the Cell and Gene Therapy in Parkinson's Disease market trends in the…

Polycythemia Vera Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Polycythemia Vera pipeline constitutes 8+ key companies continuously working towards developing 10+ Polycythemia Vera treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Polycythemia Vera Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…

Myelofibrosis Market Insights Highlight Expanding Outlook Till 2034, DelveInsigh …
The Key Myelofibrosis Companies in the market include - Lynk Pharmaceuticals, Samus Therapeutics, Taiga Biotechnologies, Bristol-Myers Squibb, Sumitomo Pharma Oncology, Inc., Keros Therapeutics, Inc., Galecto Biotech AB, Actuate Therapeutics Inc., Karyopharm Therapeutics, AbbVie, Sierra Oncology, and others.
DelveInsight's "Myelofibrosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Myelofibrosis, historical and forecasted epidemiology as well as the Myelofibrosis market trends in the United States, EU4 (Germany, Spain,…

Asthma Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Obser …
The Key Asthma Companies in the market inlcude - GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharmaceuticals, Inc., AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharmaceuticals, Genentech Research, Roche, Suzhou Connect Biopharmaceuticals, Avalo Therapeutics, 4D Pharma plc, Regeneron Pharmaceuticals, RAPT Therapeutics, Inc., Incyte Corporation, Areteia Therapeutics, Suzhou Connect Biopharmaceuticals, Ltd., Cumberland Pharmaceuticals, Pulmatrix Inc., and others.
DelveInsight's "Asthma Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Asthma, historical and…
More Releases for Advanced
Advanced Oxidation Technologies Market Size, Share 2021, Impressive Industry Gro …
The Advanced Oxidation Technologies Market is poised to take off in upcoming years hence showing a highly positive outlook through 2020-2028, according to a recently released report. Advanced Oxidation Technologies Market report covers industry chain analysis, latest market trends & dynamics along with cost profit analysis of major key players which focuses on expansion rate, prices, competition, size, prices, and value chain analysis of those leaders in the market.
The…
Medical Ceramics Market Analysis and Industry Forecast | Advanced Ceramics Resea …
Allied Market Research published a new report, titled, “Medical Ceramics Market by Type (Aluminum Oxide, Zirconia, and Carbon, Hydroxyapatite, Glass & Bioglass, Zirconia Alumina, Bioresorbable Ceramics, and Piezo Ceramics), by Application (Surgical Instruments, Diagnostic Equipment, Orthopedic Implants, Electronic Implants, Dental Implants, Disposables, and Packaging) – Global Opportunity Analysis and Industry Forecast, 2014 – 2022.” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five…
Skincell Advanced Reviews – Does Skincell Advanced Really Work?
People want clear, blemish-free skin! However, most people have skin tags, moles, and warts. Some causes are known, while some blemishes are caused without any reason at all. When a regular skincare regimen fails, people turn to costly surgeries and medications. Cleansing and moisturizing might not work well for all. All skin types are not the same, and toners and skincare creams seldom give long-lasting benefits.
Get Skincell Advanced From Its…
Global Advanced Oxidation Technologies Market 2019- 2025 || A-Zone Technologies, …
Synopsis of the Advanced Oxidation Technologies Market:
Latest Report on Advanced Oxidation Technologies Market deliberates the effect of various Factors influencing the market growth and drivers. Its further sheds light on market overview, key manufacturers, strategic adopted by them, size, latest trends and types, revenue, gross margin with regional analysis and forecast to 2025.
Overview of the Advanced Oxidation Technologies Market Report:
Advanced Oxidation Technologies Market report includes knowledge about the market overview…
Global Advanced Materials Market - 3M Company, DowDuPont Inc, Hexcel Corporation …
A New fresh research report presented by KD Market Insights provides a detailed analysis of “Advanced Materials Market - By Product type (Structural Material, Functional Material, Emerging Material) By End User (Building & Construction, Automotive, Aerospace, Defense, Marine, Electrical & Electronics, Healthcare, Oil & Gas and Energy, Others) & Global Region - Market Size, Trends, Share and Forecast 2018-2023” research report will include all the major trends and technologies that…
Global Advanced Materials Market: 3M Company, DowDuPont Inc, Hexcel Corporation, …
A New fresh research report presented by KD Market Insights provides a detailed analysis of “Advanced Materials Market 2017: Market Size, Trends & Opportunity Outlook – Forecast to 2023” research report will include all the major trends and technologies that play an important role in market growth in the predicted span of 6 years. It also presents the overview of industry players, advantages, challenges the business is going through. The…